Ankit Mahadevia

Insider Reports History

Location
C/O Spero Therapeutics, Inc., 675 Massachusetts Ave., 14 Th Floor, Cambridge, MA
Signature
/s/ Maegan Deare, Attorney-in-Fact for Ankit Mahadevia
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ankit Mahadevia:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Spero Therapeutics, Inc. Director Common Stock 703K $1.39M $1.97 Aug 28, 2025 Direct

Insider Reports Filed by Ankit Mahadevia

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRO Spero Therapeutics, Inc. Aug 28, 2025 1 -$12.9K 4 Sep 3, 2025 Director
SPRO Spero Therapeutics, Inc. Jun 12, 2025 1 $0 4 Jun 16, 2025 Director
SPRO Spero Therapeutics, Inc. Feb 5, 2025 2 -$54K 4 Feb 5, 2025 Director
SPRO Spero Therapeutics, Inc. Aug 27, 2024 1 -$7.98K 4 Aug 29, 2024 Director
SPRO Spero Therapeutics, Inc. May 29, 2024 1 $0 4 May 30, 2024 Director
SPRO Spero Therapeutics, Inc. Feb 2, 2024 1 -$87.4K 4 Feb 5, 2024 Director
SPRO Spero Therapeutics, Inc. Oct 5, 2023 1 $0 4 Oct 10, 2023 Director
SPRO Spero Therapeutics, Inc. Aug 28, 2023 1 -$11.4K 4 Aug 30, 2023 Director
SPRO Spero Therapeutics, Inc. Feb 3, 2023 1 -$22.2K 4 Feb 6, 2023 CEO and President, Director
SPRO Spero Therapeutics, Inc. Feb 1, 2023 1 $0 4 Feb 3, 2023 CEO and President, Director
SPRO Spero Therapeutics, Inc. Feb 1, 2022 2 $0 4 Feb 3, 2022 CEO and President, Director
SPRO Spero Therapeutics, Inc. Dec 27, 2021 3 -$69.5K 4 Dec 29, 2021 CEO and President, Director
SPRO Spero Therapeutics, Inc. Aug 26, 2021 1 $0 4 Aug 30, 2021 CEO and President, Director